ArticleCureus2024
Asymptomatic Peripheral Arterial Disease Among Jordanian Patients With Diabetic Foot Ulcer.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The Role of the Notch1 Signaling Pathway in the Pathogenesis and Treatment of Diabetic Foot: A Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Review
- Review
- Assessing hemodynamic changes in diabetic patients with and without peripheral arterial disease using dynamic vascular optical spectroscopy.Biomedical engineering online · 2026Article
- Potential Molecular Biomarkers for Predicting and Monitoring Complications in Type 2 Diabetes Mellitus.Molecules (Basel, Switzerland) · 2025Review
- Comprehensive evaluation of combined AngioJet and drug-coated balloon therapy for diabetic foot ulcers with lower extremity arterial occlusive disease.American journal of translational research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Peripheral arterial disease (PAD) is a common disorder that is usually associated with leg symptoms such as intermittent claudication (IC), which could be masked by peripheral neuropathy in diabetic patients. In this study, we aimed to assess the prevalence and associated risk factors of asymptomatic PAD among Jordanian patients with diabetic foot ulcers. Methods A cross-sectional study involving diabetic foot patients attending the diabetic foot clinic at the Medical City in Royal Medical Services in Amman, Jordan, was conducted from January 2023 to March 2024. The criteria for the diagnosis of asymptomatic PAD were as follows: patients with toe brachial index (TBI) <0.7 and no leg symptoms as determined by the San Diego Claudication Questionnaire (SDCQ). Results PAD was observed in 38 out of 133 patients (28.6%). Of these, 26 patients (68.4%) had asymptomatic PAD. Statistically significant associations were observed between PAD and male gender, former smoking, cerebrovascular disease (CVD), age, duration of diabetes, and high-density lipoprotein (HDL). Multiple binary logistic regression showed that ex-smoking and age had a significant impact on developing PAD; ex-smoker patients were 4.75 times [95% confidence interval (CI): 1.26-17.90, p=0.021] more likely to have PAD than non-smokers, and the odds ratio (OR) of having PAD increased by 1.05 times for each additional year of patient age (95% CI: 1.004-1.095, p=0.032). In investigating factors associated with asymptomatic PAD, only hypertension showed significant results. Conclusions The prevalence of asymptomatic PAD is relatively high in diabetic foot patients. PAD may delay wound healing and lead to limp loss and poorer quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.